NPI registry status
Active
2026 NPPES data Cardiovascular Disease Physician NPI 1275532129 MD
Verify on CMS → Samer Azouz, MD
Cardiovascular Disease Physician in Wexford, Pennsylvania.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 24,810 in Cardiovascular Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
9K
Medicare Part D claims · 1K beneficiaries · Cardiovascular Disease Physician avg: 3K
Generic prescribing
81%
generic claims · 19% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$9.5K
139 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Samer Azouz, MD filed 8,902 Medicare Part D claims in 2023 as a Cardiovascular Disease Physician in Wexford, Pennsylvania, prescribing 81% generic.
- 9K
- Part D claims, 2023
- 81%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥98th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Samer Azouz, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1275532129), first enumerated 07/21/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 8,902 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$9.5K in reported industry payments (139 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Pennsylvania statewide board action statistics are published annually — these figures describe aggregate state activity, not Samer Azouz, MD's individual license status. Verify directly with the state medical board.
Source: PA-BOM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1275532129 · Cardiovascular Disease Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-MID · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1275532129
- ENUM-LEGACY 2005
- TAX-MID 25K Cardiovascular Disease
- RX-MID 8,902
- BOOK-LIGHT 1,354 in Pennsylvania
- PHOTO-ENUM Indiresha Iyer · 2005
Samer Azouz, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
8,902 ≥ 98th percentile 98% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Samer Azouz, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Samer Azouz, MD?
Quality data not reportedPrimary specialty
Cardiovascular Disease Physician
Medicare Part D claims
8,902 194% vs specialty avg
Specialty distribution in Pennsylvania
How Cardiovascular Disease Physician compares to other specialties among Pennsylvania providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Cardiovascular Disease Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1275532129 |
|---|---|
| Specialty | Cardiovascular Disease Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 07/21/2005 |
Hospital and facility affiliations
Facilities where Samer Azouz, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Allegheny Clinic
Canonsburg, PA
Bloomington Medical Services LLC
Wooster, OH
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Samer Azouz, MD. Source: openpaymentsdata.cms.gov.
Total received
$9.5K
Largest payer
Janssen Pharmaceuticals, Inc
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to Samer Azouz, MD. To verify Samer Azouz, MD's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Samer Azouz, MD - brand share 19.0%
Cardiovascular Disease Physician average
19% brand-name claims vs 81% generic, on 8,902 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
8,902
Total Claims
$1.8M
Total Drug Cost
1,091
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 21,601
- Total Day Supply
- 644,311
- Brand vs Generic
- 19% brand / 81% generic
- Brand Drug Cost
- $1.5M
- Generic Drug Cost
- $218K
- Antibiotic Claims
- 25
Patient Demographics
- Average Patient Age
- 74.8 years
- Avg HCC Risk Score
- 1.45
- Gender Split
- 43% female / 57% male
- Age Distribution
- <65: 45, 65-74: 510, 75-84: 420, 85+: 116
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Samer Azouz, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Metoprolol Succinate
Metoprolol Succinate
758 claims
- Atorvastatin Calcium
Atorvastatin Calcium
708 claims
- Eliquis
Eliquis
579 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
512 claims
- Amlodipine Besylate
Amlodipine Besylate
492 claims
- Lisinopril
Lisinopril
396 claims
- Losartan Potassium
Losartan Potassium
376 claims
- Metoprolol Tartrate
Metoprolol Tartrate
367 claims
| Drug | Claims |
|---|---|
| Metoprolol Succinate | 758 |
| Atorvastatin Calcium | 708 |
| Eliquis Apixaban | 579 |
| Rosuvastatin Calcium | 512 |
| Amlodipine Besylate | 492 |
| Lisinopril | 396 |
| Losartan Potassium | 376 |
| Metoprolol Tartrate | 367 |
| Carvedilol | 329 |
| Furosemide | 262 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Cardiovascular Disease Physician Overview
How Samer Azouz, MD fits within the Cardiovascular Disease Physician landscape nationally.
24,810
Cardiovascular Disease Physician Providers in US
54
States with Cardiovascular Disease Physician
3,033
Avg Claims per Provider
Samer Azouz, MD's 8,902 claims are above the specialty average of 3,033.
Nationwide Cardiovascular Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Azouz, both outside Pennsylvania so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Cardiovascular Disease Physician Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Azouz.
One of 1,354 Cardiovascular Disease Physician providers enrolled in Pennsylvania, 5 are shown here.
Dr. Abdul Abbasi
MD
Uniontown, PA
Dr. Richard Abramowitz
MD
Kingston, PA
Dr. Sandra Abramson
MD
Wynnewood, PA
Dr. Elizabeth Adams
DO
Hershey, PA
Dr. David Addley
D.O.
Philadelphia, PA
Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Samer Azouz, MD's specialty? ▼
Samer Azouz, MD specializes in Cardiovascular Disease Physician and practices in Wexford, Pennsylvania. Credentials: MD.
How much does Samer Azouz, MD prescribe under Medicare Part D? ▼
In 2023, Samer Azouz, MD wrote 8,902 Medicare Part D claims totaling $1.8M in drug costs for 1,091 beneficiaries.
Where is Samer Azouz, MD located? ▼
Samer Azouz, MD is located at 12311 PERRY HWY, Wexford, PA, 15090. Phone: (878) 332-4214.
What is Samer Azouz, MD's NPI number? ▼
Samer Azouz, MD's National Provider Identifier (NPI) is 1275532129, issued on 07/21/2005.
Does Samer Azouz, MD prescribe more brand-name or generic drugs? ▼
Samer Azouz, MD's prescribing is 19% brand-name and 81% generic drugs by claim count, with $1.5M in brand drug costs.
How many Cardiovascular Disease Physician providers are there in the US? ▼
There are 24,810 Cardiovascular Disease Physician providers across 54 states in the US. The average Cardiovascular Disease Physician provider writes 3,033 Medicare Part D claims per year.
What drugs does Samer Azouz, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Samer Azouz, MD's most frequently prescribed drugs include Metoprolol Succinate, Atorvastatin Calcium, Eliquis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Samer Azouz, MD accept Medicare? ▼
Samer Azouz, MD appears in CMS Medicare data with 8,902 Part D claims and 1,091 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Samer Azouz, MD's credentials? ▼
Samer Azouz, MD's NPI is 1275532129 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.